World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
142
Citations
65963
World Ranking
154
National Ranking
104

Medicine

D-Index
143
Citations
67042
World Ranking
1523
National Ranking
885

Marc E. Rothenberg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marc E. Rothenberg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 633 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marc E. Rothenberg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marc E. Rothenberg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 142 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award

Overview

Marc E. Rothenberg is affiliated with Cincinnati Children's Hospital Medical Center in the United States. Their research primarily spans the field of medicine, with a significant focus on surgery, rheumatology, immunology, physiology, and infectious diseases as subfields of study.

Their work centers on topics related to eosinophilic conditions and immune pathways, including:

  • Eosinophilic Esophagitis
  • Eosinophilic Disorders and Syndromes
  • IL-33, ST2, and ILC Pathways
  • Asthma and respiratory diseases
  • Dermatology and Skin Diseases
  • Gastrointestinal disorders and treatments
  • Esophageal and GI Pathology

Rothenberg's publications have appeared predominantly in several key scientific venues, including:

  • Journal of Allergy and Clinical Immunology
  • Gastroenterology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The American Journal of Gastroenterology
  • The Journal of Allergy and Clinical Immunology In Practice

Among their recent papers are:

  • "Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis" (2022), published in New England Journal of Medicine
  • "Eosinophil responses during COVID-19 infections and coronavirus vaccination" (2020), published in Journal of Allergy and Clinical Immunology
  • "Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis" (2020), published in New England Journal of Medicine
  • "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial" (2020), published in Journal of Allergy and Clinical Immunology
  • "International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature" (2022), published in Clinical Gastroenterology and Hepatology

Frequent collaborators who have coauthored extensively with Rothenberg include:

  • Evan S. Dellon
  • Margaret H. Collins
  • Ikuo Hirano
  • Jonathan M. Spergel
  • Glenn T. Furuta

Best Publications

  • Eosinophilic esophagitis: Updated consensus recommendations for children and adults

    Chris A. Liacouras;Glenn T. Furuta;Ikuo Hirano;Dan Atkins

  • Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

    Glenn T. Furuta;Chris A. Liacouras;Margaret H. Collins;Sandeep K. Gupta

  • Eosinophilic gastrointestinal disorders (EGID)

    Marc E Rothenberg

  • Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

    Evan S. Dellon;Chris A. Liacouras;Javier Molina-Infante;Glenn T. Furuta

  • Eosinophils: Biological Properties and Role in Health and Disease

    Simon P. Hogan;Helene F. Rosenberg;Redwan Moqbel;Simon Phipps

  • Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

    Carine Blanchard;Ning Wang;Keith F. Stringer;Anil Mishra

  • Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.

    Eduardo A. Garcia-Zepeda;Marc E. Rothenberg;Robert T. Ownbey;Jocelyn Celestin

  • An etiological role for aeroallergens and eosinophils in experimental esophagitis

    Anil Mishra;Simon P. Hogan;Eric B. Brandt;Marc E. Rothenberg

  • Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

    Princess U. Ogbogu;Bruce S. Bochner;Joseph H. Butterfield;Gerald J. Gleich

  • MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression

    Thomas X. Lu;Ariel Munitz;Marc E. Rothenberg

  • A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis

    Michael R. Konikoff;Richard J. Noel;Carine Blanchard;Cassie Kirby

  • Treatment of patients with the hypereosinophilic syndrome with mepolizumab

    Marc E. Rothenberg;Amy D. Klion;Florence E. Roufosse;Jean Emmanuel Kahn

  • Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia

    Marc E. Rothenberg;James A. MacLean;Eric Pearlman;Andrew D. Luster

  • Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis

    Nives Zimmermann;Nina E. King;Johanne Laporte;Ming Yang

  • Targeting eosinophils in allergy, inflammation and beyond

    Patricia C. Fulkerson;Marc E. Rothenberg

  • Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial

    Jonathan M. Spergel;Marc E. Rothenberg;Margaret H. Collins;Glenn T. Furuta

  • Postnatal mammary gland development requires macrophages and eosinophils.

    Valérie Gouon-Evans;Marc E. Rothenberg;Jeffrey W. Pollard

  • Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

    M E Rothenberg;W F Owen;D S Silberstein;J Woods

  • Pathophysiology of Eosinophilic Esophagitis.

    Kelly M. O’Shea;Seema S. Aceves;Evan S. Dellon;Sandeep K. Gupta

  • Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis

    Miguel L. Stein;Margaret H. Collins;Joyce M. Villanueva;Jonathan P. Kushner

  • Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression

    Marc E. Rothenberg;Andrew D. Luster;Philip Leder

  • CLINICAL-ALIMENTARY TRACT A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis

    Michael R. Konikoff;Richard J. Noel;Carine Blanchard;Cassie Kirby

Frequent Co-Authors

Margaret H. Collins
Margaret H. Collins Cincinnati Children's Hospital Medical Center
Simon P. Hogan
Simon P. Hogan Cincinnati Children's Hospital Medical Center
Evan S. Dellon
Evan S. Dellon University of North Carolina at Chapel Hill
Fred D. Finkelman
Fred D. Finkelman University of Cincinnati
Burton Zweiman
Burton Zweiman University of Pennsylvania
Lisa J. Martin
Lisa J. Martin Cincinnati Children's Hospital Medical Center
Glenn T. Furuta
Glenn T. Furuta University of Colorado Denver
Jonathan M. Spergel
Jonathan M. Spergel University of Pennsylvania
Gary W. Falk
Gary W. Falk University of Pennsylvania
Anil Mishra
Anil Mishra Tulane University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Immunology in the USA, pursuing advanced degrees in nursing specialties can be a strategic way to apply immunological knowledge in clinical settings. Many are turning to online pmhnp programs with clinical placement, which provide both flexible learning and hands-on experience, essential for a strong healthcare career.

Cost is often a barrier, but there are cheap psych NP programs available, making advanced nursing education more accessible for prospective students interested in mental health and immunology intersections.

Career progression and salary transparency are also vital for planning. Resources such as dnp salary transparency offer insights into expected earnings across states, helping graduates assess the financial benefits of pursuing Nurse Practitioner roles with immunological expertise.

Additionally, those interested in progressing from Family Nurse Practitioner roles may explore specialized tracks such as Acute Care Nurse Practitioner programs. Guidance on this transition can be found through detailed acnp programs, which emphasize advanced clinical skills applicable in immunology-related acute care settings.

Best Scientists Citing Marc E. Rothenberg

Trending Scientists

Recently Published Articles